Virpax Pharmaceuticals - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Is DLL3 becoming the most strategic biomarker target in neuroendocrine oncology?

realme Buds T310 in Agile White: top true wireless earbuds under ₹2,000

realme Buds T310 review: Are these the best budget ANC earbuds under ₹2,000?

Why support-platform strategy may become a differentiator in schizophrenia treatment markets

Representative image of gold bars and tanker traffic in the Strait of Hormuz, illustrating why gold prices climbed to a one-month high even as the waterway was declared completely open.

What gold’s latest rally says about geopolitical hedging after the Strait of Hormuz reopening

Virpax Pharmaceuticals is advancing non-opioid pain management with NES100, its novel intranasal enkephalin product, through an extended NIH collaboration.

Read More

Pharma Industry News

Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension…

byPallavi Madhiraju

November 23, 2024

web analytics